Voxelotor for Improving Oxygen Saturation in Adults

NCT05289570 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Terminated by new sponsor due to funding issues.

Conditions

Acute Lung Injury
End Stage Lung Disease

Interventions

DRUG: Voxelotor

Sponsor

Duke University